STOCK TITAN

PHARM-BIO SERV INC (PBSV) EPS by Year

PBSV

PHARM-BIO SERV INC lost $0.00 per diluted share in fiscal year 2025. This represents an increase of 88.2% from the prior fiscal year. Over the trailing 12 months, Q4 FY2025 through Q3 FY2026, the same line adds up to $0.00 per diluted share. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters PHARM-BIO SERV INC has filed alongside them.

FY2025 annual
EPS (Diluted) $0.00
YoY +88.2%
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Jul 31, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

PBSV EPS (Diluted) by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-K
EPS (Diluted)$0.00$0.00+88.2%-$0.03-159.6%$0.06N/AN/AN/AN/AN/A-$0.06-454.5%-$0.01-115.9%$0.07-32.4%$0.10-50.7%$0.21+1.5%$0.20$0.14

TTM is the trailing twelve months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings.

PBSV EPS (Diluted) by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-K
EPS (Diluted)$0.00$0.01+150.0%$0.00-$0.01+88.4%-$0.01-164.3%$0.00+144.4%$0.00+100.0%-$0.07$0.01-$0.01-$0.01N/A

What diluted earnings per share means

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.

More PHARM-BIO SERV INC financials

Frequently Asked Questions

What was PHARM-BIO SERV INC's diluted earnings per share in fiscal year 2025?

PHARM-BIO SERV INC lost $0.00 per diluted share in fiscal year 2025.

How fast is PHARM-BIO SERV INC's diluted earnings per share growing?

PHARM-BIO SERV INC (PBSV) diluted earnings per share rose by 88.2% year over year, from -$0.03 to $0.00 in fiscal year 2025.

What is PHARM-BIO SERV INC's diluted earnings per share over the last twelve months?

PHARM-BIO SERV INC (PBSV) reported $0.00 per diluted share over the trailing 12 months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings.

Across the 15 fiscal years this page covers, PHARM-BIO SERV INC (PBSV) diluted earnings per share went from $0.14 in fiscal year 2011 to $0.00 in fiscal year 2025.

PHARM-BIO SERV INC (PBSV) reported $0.00 in diluted earnings per share in Q3 2026.

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what PHARM-BIO SERV INC (PBSV) reported on that line in every period on record.